aldosterone has been researched along with Deficiency, Vitamin D in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-three consecutive patients with essential hypertension and hypovitaminosis D underwent therapy with cholecalciferol 50 000 IU/week orally for 8 weeks." | 3.83 | Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. ( Bacca, A; Bernini, G; Bruno, RM; Carrara, D; Duranti, E; Ghiadoni, L; Taddei, S, 2016) |
| "Valsartan treatment did not affect plasma PTH, although treatment reduced diastolic blood pressure (P = ." | 2.87 | Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial. ( Bislev, LS; Bjerregaard Pedersen, E; Langagergaard Rødbro, L; Nørgaard Bech, J; Rejnmark, L; Rolighed, L; Sikjaer, T, 2018) |
| "Vitamin D deficiency is associated with hypertension." | 1.46 | Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population. ( Gao, M; Li, H; Liu, H; Xu, X; Zhang, J; Zhang, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, L | 1 |
| Xu, XJ | 1 |
| Zhang, JS | 1 |
| Liu, HM | 1 |
| Renke, G | 1 |
| Starling-Soares, B | 1 |
| Baesso, T | 1 |
| Petronio, R | 1 |
| Aguiar, D | 1 |
| Paes, R | 1 |
| Simpson, CA | 1 |
| Zhang, JH | 1 |
| Vanderschueren, D | 1 |
| Fu, L | 1 |
| Pennestri, TC | 1 |
| Bouillon, R | 1 |
| Cole, DEC | 1 |
| Carpenter, TO | 1 |
| Zhang, M | 1 |
| Xu, X | 1 |
| Liu, H | 1 |
| Li, H | 1 |
| Zhang, J | 1 |
| Gao, M | 1 |
| Bislev, LS | 1 |
| Langagergaard Rødbro, L | 1 |
| Nørgaard Bech, J | 1 |
| Bjerregaard Pedersen, E | 1 |
| Rolighed, L | 1 |
| Sikjaer, T | 1 |
| Rejnmark, L | 1 |
| Fernández-Juárez, G | 1 |
| Luño, J | 1 |
| Barrio, V | 1 |
| de Vinuesa, SG | 1 |
| Praga, M | 1 |
| Goicoechea, M | 1 |
| Lahera, V | 1 |
| Casas, L | 1 |
| Oliva, J | 1 |
| Morgado-Pascual, JL | 1 |
| Rayego-Mateos, S | 1 |
| Valdivielso, JM | 1 |
| Ortiz, A | 1 |
| Egido, J | 1 |
| Ruiz-Ortega, M | 1 |
| Grübler, MR | 1 |
| Gaksch, M | 1 |
| Kienreich, K | 1 |
| Verheyen, N | 1 |
| Schmid, J | 1 |
| Ó Hartaigh, BW | 1 |
| Richtig, G | 1 |
| Scharnagl, H | 1 |
| Meinitzer, A | 1 |
| Pieske, B | 1 |
| Fahrleitner-Pammer, A | 1 |
| März, W | 1 |
| Tomaschitz, A | 1 |
| Pilz, S | 1 |
| Zhang, W | 1 |
| Zheng, X | 1 |
| Wang, Y | 1 |
| Xiao, H | 1 |
| Carrara, D | 2 |
| Bruno, RM | 1 |
| Bacca, A | 2 |
| Taddei, S | 2 |
| Duranti, E | 2 |
| Ghiadoni, L | 2 |
| Bernini, G | 2 |
| Bernini, M | 1 |
| Rugani, I | 1 |
| Virdis, A | 1 |
| Nguyen, DN | 1 |
| Nguyen, LT | 1 |
| Luong, Kv | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Controlled Trial of Vitamin D Supplementation in Infants and Children: Effects of Vitamin D Dose and Genotype of the Binding Protein[NCT01050387] | 193 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Styrian Vitamin D Hypertension Trial: A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Effects of Vitamin D Supplementation on Systolic Ambulatory Blood Pressure in Vitamin D Deficient Hypertensive Patients[NCT02136771] | Phase 4 | 200 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aldosterone and Deficiency, Vitamin D
| Article | Year |
|---|---|
Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress.
Topics: Aldosterone; Calcitriol; Calcium; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Heart | 2023 |
3 trials available for aldosterone and Deficiency, Vitamin D
| Article | Year |
|---|---|
Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Blood Pressure; Cholecalciferol; Double-Blind M | 2018 |
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2013 |
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
Topics: Aged; Aldosterone; Dietary Supplements; Double-Blind Method; Female; Humans; Hypertension; Male; Mid | 2016 |
8 other studies available for aldosterone and Deficiency, Vitamin D
| Article | Year |
|---|---|
Association between Vitamin D Deficiency and Levels of Renin and Angiotensin in Essential Hypertension.
Topics: Adult; Aldosterone; Angiotensins; Asian People; Blood Pressure; Essential Hypertension; Female; Huma | 2022 |
Relationship of Total and Free 25-Hydroxyvitamin D to Biomarkers and Metabolic Indices in Healthy Children.
Topics: Aldosterone; Biomarkers; Blood Glucose; Calcium; Child; Child, Preschool; Female; Glycated Hemoglobi | 2020 |
Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Blood Pressure; Blood Pres | 2017 |
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.
Topics: ADAM Proteins; ADAM17 Protein; Aldosterone; Cell Line; Cell Proliferation; Epithelial Cells; ErbB Re | 2015 |
Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
Topics: Aged; Aldosterone; Biomarkers; Case-Control Studies; China; Humans; Male; Middle Aged; Organ Size; P | 2016 |
Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Cholecalciferol; Endoth | 2016 |
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Cholecalciferol; Essential Hypertension; Female; Humans; H | 2014 |
Vitamin D deficiency in primary aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; | 2006 |